B

바이오플러스

099430KOSDAQ기초 의약물질 제조업

59.2 / 100

Reference Date: 2026-06-10

Financial Score23.0 / 40
News Sentiment20.2 / 25
Momentum6.0 / 20
Disclosure10.0 / 15
AI Analysis: PER is significantly undervalued vs. peers but Operating Profit is on a declining trend. Plunged 16.8% over the past month, and news sentiment is positive.

Company InformationBased on 2025 Annual Report

Business Overview

BioPlus is a company specializing in the development and sale of medical devices, bio-pharmaceuticals, and bio-cosmetics, leveraging technologies such as MDM and temperature-sensitive materials to enhance product performance. To expand globally, the company has established a foreign subsidiary in Hainan, China, and operates a large-scale factory in Chungcheongbuk, South Korea, focusing on improving profitability.

Number of Employees

187people

Average Salary

60.9M KRW

Score Calculation Basis

Detailed Financial Score

PER
18.56Industry Average 27.716.5Point

Lower than industry avg (good)

PBR
1.48Industry Average 1.744.0Point

In line with industry avg

ROE
11.67Industry Average -6.033.5Point

Well below industry avg

Debt Ratio
6.54Industry Average 6.624.0Point

In line with industry avg

Trend 2023~20255.0 / 10 points
Revenue Growth Rate
2.5 / 3

Avg ▲19.5% (2-year basis)

Operating Profit Growth Rate
0.0 / 3

Avg ▼26.1% (2-year basis)

ROE Trend
2.5 / 4

Avg ROE 15.2% (declining, 3yr)

Detailed News Sentiment

8 totalPositive 7Neutral 1Negative 0Average Sentiment Score 80.6

Detailed Momentum

52-week position1.0Point

Near 52w low (4%, downtrend)

Current 4,695Won52-week high 7,84052-week low 4,550
1-month return0.0Point

1m -16.76% (strong drop)

Volume trend5.0Point

Volume flat

Detailed Disclosure

2 totalPositive 0Neutral 2Negative 0
  • Neutral기업설명회(IR)개최2026-05-27
  • Neutral분기보고서 (2026.03)2026-05-14